Asthma Boosts Abdominal Aneurysm Rupture Risk (CME/CE)
(MedPage Today) -- Use of asthma meds were linked to abdominal aortic aneurysm (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 12, 2016 Category: Allergy & Immunology Source Type: news
Recent asthma may be linked with abdominal aneurysm rupture
GPs should be alert to signs of abdominal aortic aneurysm in older patients with asthmaRelated items from OnMedicaTreatment failure more likely in older asthma patients 65-year-old men offered aneurysm screeningAbdominal aortic aneurysm screeningVigilance required by asthma patients in winter Unsafe asthma prescribing threatens 22,000 people’s lives (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 12, 2016 Category: UK Health Source Type: news
Asthma Diagnosis Tied to Higher Risk for Abdominal Aortic Aneurysm Rupture (FREE)
By Kelly Young
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
A recent diagnosis of asthma is associated with higher risk for rupture in older patients with abdominal aortic aneurysm (AAA), according to an observational study in Arteriosclerosis, Thrombosis … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 12, 2016 Category: Primary Care Source Type: news
Asthma May Raise Risk for Abdominal Aneurysm
Airway disease also linked to greater rupture risk in body's main artery, study suggests
Source: HealthDay
Related MedlinePlus Pages: Aortic Aneurysm, Asthma, Seniors' Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 11, 2016 Category: Consumer Health News Source Type: news
Asthma May Raise Risk for Abdominal Aneurysm
THURSDAY, Feb. 11, 2016 -- People 50 and older who have had recent asthma activity appear to be at an increased risk of abdominal aortic aneurysm, a new study suggests.
An abdominal aortic aneurysm is a weak spot in the body's main artery, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 11, 2016 Category: Journals (General) Source Type: news
Medtronic launches Valiant TAAA stent graft study
Medtronic (NYSE:MDT) said today it enrolled the 1st patient in a clinical study of its Valiant TAAA stent graft system designed as a minimally invasive treatment for thoracoabdominal aortic aneurysm.
The Valiant TAAA stent graft system is designed to operate as an off-the-shelf endovascular solution for patients suffering from aortic aneurysms, which are dangerous bulging or ballooning segments in the wall of the aorta that can cause sudden death if untreated, Medtronic said.
“The mortality rate is 25 percent when treating a thoracoabdominal aortic aneurysm with an open surgical technique, which involves cutting ope...
Source: Mass Device - February 9, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Clinical Trials Stent Grafts Medtronic Source Type: news
TriVascular loses appeal in patent spat with vascular stent inventor
TriVascular Technologies (NSDQ:TRIV) last Friday lost an appeal in a vascular stent patent spat after a Federal Circuit court upheld a Patent Trial and Appeal Board ruling that found the stent’s patent, held by a separate inventor, was not invalid due to obviousness.
The court upheld the ruling on the grounds that TriVascular didn’t demonstrate that the patent, held by Shaun Samuels, was invalid because of obviousness, nor did they find that the board was in error in its claims construction process, according to court documents.
“…We find no error in the board’s claim construction or its judgme...
Source: Mass Device - February 8, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Legal News Stents TriVascular Source Type: news
Endologix, TriVascular Technologies close $211m merger
Endologix (NSDQ:ELGX) and TriVascular Technologies (NSDQ:TRIV) said yesterday that they closed their $221 million merger, uniting 2 of the stent graft market’s smaller players.
Both companies makes devices for treating abdominal aortic aneurysms; Irvine, Calif.-based Endologix makes 2 lines of stent grants, the Nellix and AFX devices, while Santa Rosa, Calif.-based TriVascular makes the Ovation stent graft.
“The completion of the merger with TriVascular is a major milestone for both companies that further enhances our technology platforms and positions the combined business for robust growth with an acceler...
Source: Mass Device - February 4, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Mergers & Acquisitions Stent Grafts Wall Street Beat Endologix Inc. TriVascular Source Type: news
Arsenal Medical wins $14m DoD contract
Arsenal Medical said today it won a contract from the U.S. Army Medical Research & Materiel Command worth more than $14 million to complete clinical and manufacturing development and regulatory submission for its ResQFoam.
Arsenal’s ResQFoam is a self-expanding biomaterial designed to be administered at the point of injury to stop blood loss in patients with severe internal bleeding in the abdomen due to life-threatening traumas. The material fills the wound and conforms to the abdominal cavity to control bleeding and can be removed before surgery, the company said.
“The strong governmental support we have ...
Source: Mass Device - December 9, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Wound Care Arsenal Medical Source Type: news
Cordis touts 4-year data on Incraft AAA stent graft
Cordis Corp. said today that 4-year data from a trial of its Incraft abdominal aortic aneurysm stent graft system showed it “performed well” in patients suffering from AAAs 4 years after treatment. Data from the study was presented at the VEITHsymposium in New York City this week.
The multi-center, open-label prospective Innovation trial reported a 97% freedom from endoleaks and no stent graft migrations after 4-years.
“With the 4-year study results demonstrating continued performance with the Incraft System in Europe, Cordis’ device is clinically established in a class of next-generation AAA dev...
Source: Mass Device - November 20, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Stent Grafts Cardinal Health Cordis Corp. Source Type: news
Bruce Forsyth undergoes successful keyhole surgery after aneurysm discovered
The veteran entertainer underwent the procedure on an abdominal aortic aneurysm last Thursday. (Source: the Mail online | Health)
Source: the Mail online | Health - November 18, 2015 Category: Consumer Health News Source Type: news
Medtronic touts Endurant AAA graft 4-year data
Medtronic (NYSE:MDT) said today that 4-year real world data from a subset of patients with challenging anatomy implanted with the Endurant AAA stent graft system showed durable outcomes. The data was presented at the VEITHsymposium in New York City.
At 4-years, no differences in IA endoleak rate or AAA diameter increases were found between subsets of patients with short necks and standard necks, the company said, and freedom from aneurysm-related mortality was 99.2% for the short neck cohort and 98.3% for standard length neck patients.
“Analysis of the patient cohort from the 4-year global Engage registry included ...
Source: Mass Device - November 17, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Stent Grafts Vascular Medtronic Source Type: news
Medtronic Touts Four-Year Stent Graft Outcomes
Selected for nearly one of every two endovascular abdominal aortic aneurysm (AAA) repairs globally, the EndurantAAA stent graft system from Medtronic plc continues to maintain durable and consistent outcomes at four years in real world settings, including challenging anatomies, according to a presentation byHence J.M. Verhagen, M.D., Ph.D., Professor and Chief of Vascular Surgery, Erasmus University Medical Center in Rotterdam, the Netherlands, on the opening day of the VEITH symposium in New York City. (Source: Medical Design Online News)
Source: Medical Design Online News - November 17, 2015 Category: Medical Equipment Source Type: news
Medtronic, Hansen to present clinical trial data at VEITHSymposium
Medtronic (NYSE:MDT) and Hansen Medical (NSDQ:HNSN) said they are slated to present new clinical information at this year’s annual VEITHSymposium in New York City.
Medtronic said today it plans to present 4-year subset data results from the ENGAGE global registry study of its Endurant AAA stent graft system.
The trial analyzed patients with hostile neck anatomies treated with the abdominal aortic aneurysm stent graft system, the Fridley, Minn.-based company said.
The company said it will present data in 9 separate presentations on its EndoAnchor system, which it obtained in its $110 million purchase of Aptus Endosyste...
Source: Mass Device - November 16, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Catheters Clinical Trials Stent Grafts Stents Hansen Medical Inc. Medtronic Source Type: news
VIVA 2015 Roundup: Medtronic touts Valiant stent graft, PAD stent-treatment data
Medtronic (NYSE:MDT) this week presented data from 2 studies of its stent systems and announced a new study of its In.Pact Admiral drug-coated balloon. The announcements were made at the VIVA physicians annual conference in Las Vegas, Nev.
The Fridley, Minn.-based medical giant presented data from a 2-year clinical trial of its Valian Captivia thoracic stent graft system for treating type B aortic dissections, reporting safety and efficacy at 2-years.
Data from the 2-year follow up of the 35-patient FDA approved IDE trial reported no post-index procedure ruptures or conversions, device related adverse events or loss of ...
Source: Mass Device - November 6, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Clinical Trials Abbott Avinger Boston Scientific C.R. Bard Cook Medical Medtronic Spectranetics Corp. TriVascular TVA Medical Vascular Dynamics Vascular Interventional Advances (VIVA) Source Type: news
